222 related articles for article (PubMed ID: 23935095)
1. Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.
Kanatsuna N; Taneera J; Vaziri-Sani F; Wierup N; Larsson HE; Delli A; Skärstrand H; Balhuizen A; Bennet H; Steiner DF; Törn C; Fex M; Lernmark Å
J Biol Chem; 2013 Oct; 288(40):29013-23. PubMed ID: 23935095
[TBL] [Abstract][Full Text] [Related]
2. Doubly Reactive INS-IGF2 Autoantibodies in Children with Newly Diagnosed Autoimmune (type 1) Diabetes.
Kanatsuna N; Delli A; Andersson C; Nilsson AL; Vaziri-Sani F; Larsson K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Elding Larsson H; Ivarsson SA; Törn C; Fex M; Lernmark Å
Scand J Immunol; 2015 Oct; 82(4):361-9. PubMed ID: 26073034
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.
Sarugeri E; Dozio N; Belloni C; Meschi F; Pastore MR; Bonifacio E
Clin Exp Immunol; 1998 Dec; 114(3):370-6. PubMed ID: 9844045
[TBL] [Abstract][Full Text] [Related]
4. No association of INS-VNTR genotype and IAA autoantibodies.
Pérez de Nanclares G; Bilbao JR; Castano L
Ann N Y Acad Sci; 2004 Dec; 1037():127-30. PubMed ID: 15699505
[TBL] [Abstract][Full Text] [Related]
5. The human insulin gene is part of a large open chromatin domain specific for human islets.
Mutskov V; Felsenfeld G
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17419-24. PubMed ID: 19805079
[TBL] [Abstract][Full Text] [Related]
6. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
7. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to post-translationally modified insulin in type 1 diabetes.
Strollo R; Vinci C; Arshad MH; Perrett D; Tiberti C; Chiarelli F; Napoli N; Pozzilli P; Nissim A
Diabetologia; 2015 Dec; 58(12):2851-60. PubMed ID: 26350612
[TBL] [Abstract][Full Text] [Related]
9. Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.
Michels AW; Landry LG; McDaniel KA; Yu L; Campbell-Thompson M; Kwok WW; Jones KL; Gottlieb PA; Kappler JW; Tang Q; Roep BO; Atkinson MA; Mathews CE; Nakayama M
Diabetes; 2017 Mar; 66(3):722-734. PubMed ID: 27920090
[TBL] [Abstract][Full Text] [Related]
10. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.
Nakayama M; Beilke JN; Jasinski JM; Kobayashi M; Miao D; Li M; Coulombe MG; Liu E; Elliott JF; Gill RG; Eisenbarth GS
J Clin Invest; 2007 Jul; 117(7):1835-43. PubMed ID: 17607359
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
12. Human islet T cells are highly reactive to preproinsulin in type 1 diabetes.
Anderson AM; Landry LG; Alkanani AA; Pyle L; Powers AC; Atkinson MA; Mathews CE; Roep BO; Michels AW; Nakayama M
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34611019
[TBL] [Abstract][Full Text] [Related]
13. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
[TBL] [Abstract][Full Text] [Related]
14. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
15. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
[TBL] [Abstract][Full Text] [Related]
16. Analysis artefacts of the INS-IGF2 fusion transcript.
Wernersson R; Frogne T; Rescan C; Hansson L; Bruun C; Grønborg M; Jensen JN; Madsen OD
BMC Mol Biol; 2015 Jul; 16():13. PubMed ID: 26220792
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a Type 1 diabetes-specific mechanism for the insulin gene-associated IDDM2 locus rather than a general influence on autoimmunity.
Tait KF; Collins JE; Heward JM; Eaves I; Snook H; Franklyn JA; Barnett AH; Todd JA; Maranian M; Compston A; Sawcer S; Gough SC
Diabet Med; 2004 Mar; 21(3):267-70. PubMed ID: 15008838
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.
Buzzetti R; Spoletini M; Zampetti S; Campagna G; Marandola L; Panimolle F; Dotta F; Tiberti C;
Diabetes Care; 2015 Mar; 38(3):513-20. PubMed ID: 25567348
[TBL] [Abstract][Full Text] [Related]
20. Microassay for glucose-induced preproinsulin mRNA expression to assess islet functional potency for islet transplantation.
Omori K; Mitsuhashi M; Todorov I; Rawson J; Shiang KD; Kandeel F; Mullen Y
Transplantation; 2010 Jan; 89(2):146-54. PubMed ID: 20098276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
